PCSA
NASDAQ · Pharmaceuticals
Processa Pharmaceuticals Inc
$2.02
-0.06 (-2.88%)
Open$2.05
Previous Close$2.08
Day High$2.16
Day Low$2.00
52W High$14.24
52W Low$1.76
Volume—
Avg Volume74.6K
Market Cap5.83M
P/E Ratio—
EPS$-10.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,726.7% upside
Current
$2.02
$2.02
Target
$36.90
$36.90
$23.79
$36.90 avg
$41.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.71M | 2.46M | 2.10M |
| Net Income | 319.8K | 302.9K | 327.4K |
| Profit Margin | 11.8% | 12.3% | 15.6% |
| EBITDA | 521.3K | 563.7K | 431.6K |
| Free Cash Flow | 364.0K | 435.1K | 285.7K |
| Rev Growth | +2.4% | +0.4% | +18.3% |
| Debt/Equity | 0.28 | 0.35 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |